New Jersey Assembly Bill A6013

New Jersey 2024-2025 Regular Session

• Introduced: 11/17/25
• Refer: 11/17/25

Caption

Prohibits sale of cosmetic products and personal care products containing 1,4-dioxane.

Impact

The implications of Bill A6013 are significant for both manufacturers and consumers. If enacted, it will lead to stricter regulations regarding the content of cosmetic and personal care products sold within New Jersey. Manufacturers will need to either reformulate their products to adhere to new limits on 1,4-dioxane or face product removal from the market. The bill establishes allowable trace concentrations for 1,4-dioxane, which are set at a maximum of 10 parts per million for cosmetic products, and stricter thresholds for personal care products, thereby aiming to reduce potential health risks associated with prolonged exposure to this substance.

Summary

Bill A6013 aims to prohibit the sale of cosmetic and personal care products that contain 1,4-dioxane, a compound recognized as a hazardous substance and potential human carcinogen. The legislation is a response to growing concerns over the health impacts associated with this chemical, which is commonly found as a manufacturing byproduct in various cosmetic and cleaning products. The bill seeks to enhance public safety by eliminating exposure to harmful chemicals in everyday items, thereby contributing to better health outcomes for consumers.

Contention

While Bill A6013 has garnered support from health advocates and environmental groups concerned about consumer safety, there may also be potential pushback from manufacturers who argue that compliance will increase production costs and limit product availability. Furthermore, the bill allows manufacturers to apply for waivers if they can demonstrate efforts to reduce 1,4-dioxane but are unable to meet the requirements. This provision aims to offer some leeway in the transition to safer products, though critics may question the effectiveness and sustainability of such waivers in practice.